Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Novartis
Deloitte
Fuji
Citi
Mallinckrodt
Farmers Insurance
Merck
Covington

Generated: January 24, 2018

DrugPatentWatch Database Preview

BUTABARBITAL Drug Profile

« Back to Dashboard

US Patents and Regulatory Information for BUTABARBITAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bundy BUTABARBITAL butabarbital sodium TABLET;ORAL 085550-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Solvay BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 083606-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 085938-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 088631-001 May 1, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Solvay BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 083898-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Whiteworth Town Plsn BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 083337-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 085772-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt BUTABARBITAL SODIUM butabarbital sodium ELIXIR;ORAL 085383-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 084292-003 Feb 9, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 085934-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Express Scripts
McKesson
Covington
QuintilesIMS
Julphar
Cerilliant
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot